Apricus Biosciences Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Apricus Biosciences

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: phoenix_rising who wrote (1547)	11/5/2015 7:49:26 PM
From: OldBoar	Read Replies (1) of 2026

Please help me understand how this works. "Additionally, the decrease was due to a $0.3 million decrease in product sales, primarily due to the Company's commercialization partners purchasing Vitaros directly from the Company's manufacturer. These decreases were partially offset by an increase in royalty revenues related to the sale of Vitaros by the Company's commercialization partners." So, the Pharma companies buy directly from manufacturer? Old Boar

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next